Acromegaly biotech Chiasma files for a $86 million IPO

The Newton, MA-based company, which was founded in 2001 and booked $9 million in sales for the 12 months ended March 31, 2015, plans to list on the NASDAQ under the symbol CHMA. Chiasma initially filed confidentially on 4/17/2015. Barclays and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.